Do crestor side effects go away?
Do Crestor side effects go away?
Crestor (rosuvastatin) is a statin used to lower LDL cholesterol, raise HDL cholesterol, and reduce triglycerides. Like all medications, it can cause side effects—some mild and transient, others more serious.
Mild side effects
- Headache, nausea, constipation: Often appear within the first days of therapy and resolve within 1–2 weeks as the body adjusts.
- Muscle aches and joint pain: May persist during treatment. If they occur, discuss with your provider; they usually improve within 1–2 weeks after stopping Crestor.
- Elevated blood sugar, rash, dizziness: Generally transient and clear in a few weeks.
Serious side effects
- Allergic reactions (hives, throat swelling): Require immediate ER attention.
- Myopathy/rhabdomyolysis: Presents as unexplained muscle weakness, tenderness, dark urine. Usually begins to resolve days after discontinuation but may take longer.
- Liver injury: Symptoms include jaundice, abdominal pain, dark urine. Can become permanent; monitoring liver enzymes is recommended.
- Cognitive impairment: Memory loss or confusion have been reported; these effects typically clear within ~3 weeks after stopping.
Impact of dose
Higher Crestor doses (20 mg) are associated with a greater incidence of side effects compared to lower doses (10 mg). Your risk also depends on age, liver/kidney function, and co‑medications.
Who should avoid Crestor?
- Active liver disease or persistent transaminase elevations
- Severe kidney impairment
- Untreated hypothyroidism
- Pregnancy or breastfeeding
- Concomitant use of interacting drugs (e.g., gemfibrozil, certain antivirals, niacin)
- Heavy alcohol use
- Asian descent may require lower starting dose
When to seek help
If mild side effects persist beyond a few weeks, or if you experience muscle pain, dark urine, jaundice, or cognitive changes, contact your healthcare provider immediately.
Sources
- Crestor (rosuvastatin) tablet, film coated [package insert]. AstraZeneca. Last updated 7/2024. Accessed Apr 25, 2025.